|
OMIM |
Link |
Information gain |
01 |
|
IGAD1
|
[NCBI]
|
0.00275891
|
|
|
enteropathy, protein-losing
|
[NCBI]
|
0.00197345
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.001821
|
|
|
hyperimmunoglobulin e-recurrent infection syndrome, autosomal recessive
|
[NCBI]
|
0.00145214
|
|
|
reticular dysgenesia
|
[NCBI]
|
0.00145214
|
|
|
IGAN1
|
[NCBI]
|
0.00144036
|
|
|
CVID
|
[NCBI]
|
0.00138588
|
|
|
SLE
|
[NCBI]
|
0.00123051
|
|
|
immune defect due to absence of thymus
|
[NCBI]
|
0.00103694
|
|
|
IBD2
|
[NCBI]
|
0.00103694
|
|
|
kenny-caffey syndrome, type 2
|
[NCBI]
|
0.00103694
|
|
|
EEC1
|
[NCBI]
|
0.000962915
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
0.000962915
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000837688
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.000614421
|
|
|
RA
|
[NCBI]
|
0.000606657
|
|
|
SLAMF1
|
[NCBI]
|
0.000579985
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.00054938
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.00054938
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000440692
|
|
|
CF
|
[NCBI]
|
0.000367542
|
|
|
OFC1
|
[NCBI]
|
0.000365563
|
|
|
SH2D1A
|
[NCBI]
|
0.000344853
|
|
|
AD
|
[NCBI]
|
0.000334754
|
|
|
BCGF
|
[NCBI]
|
0.000294534
|
|
|
IGSF4
|
[NCBI]
|
0.000250413
|
|
|
XLP1
|
[NCBI]
|
0.000194362
|
|
|
CD83
|
[NCBI]
|
0.000171411
|
|
|
MAG
|
[NCBI]
|
0.000165795
|
|
|
A1BG
|
[NCBI]
|
0.000162875
|
|
|
WAS
|
[NCBI]
|
0.000159304
|
|
|
SCIDX1
|
[NCBI]
|
0.000154512
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
0.000141984
|
|
|
IGHG1
|
[NCBI]
|
0.000139962
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
0.000138654
|
|
|
TAPBP
|
[NCBI]
|
0.000134571
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
0.000130748
|
|
|
MADCAM1
|
[NCBI]
|
0.000130283
|
|
|
AT
|
[NCBI]
|
0.00012825
|
|
|
DKC
|
[NCBI]
|
0.000125166
|
|
|
JAM2
|
[NCBI]
|
0.000116897
|
|
|
IGLC1
|
[NCBI]
|
0.000114123
|
|
|
agammaglobulinemia, non-bruton type, autosomal recessive
|
[NCBI]
|
0.000112488
|
|
|
ARMD1
|
[NCBI]
|
0.000112302
|
|
|
CEACAM5
|
[NCBI]
|
0.000111238
|
|
|
HMCN1
|
[NCBI]
|
0.000109856
|
|
|
gamma-a-globulin, defect in assembly of
|
[NCBI]
|
0.000103331
|
|
|
FSGS3
|
[NCBI]
|
0.000103331
|
|
|
hypersensitivity pneumonitis, familial
|
[NCBI]
|
0.000103331
|
|
|
lymphokine deficiency
|
[NCBI]
|
0.000103331
|
|
|
fanconi-like syndrome
|
[NCBI]
|
0.000103331
|
|
|
OK
|
[NCBI]
|
0.000103331
|
|
|
myeloma, multiple
|
[NCBI]
|
9.46258e-05
|
|
|
IGKC
|
[NCBI]
|
8.7202e-05
|
|
|
IGSF4B
|
[NCBI]
|
8.56663e-05
|
|
|
ICAM5
|
[NCBI]
|
8.3836e-05
|
|
|
omenn syndrome
|
[NCBI]
|
8.22093e-05
|
|
|
TNFSF13B
|
[NCBI]
|
8.1905e-05
|
|
|
MG
|
[NCBI]
|
8.11708e-05
|
|
|
TCRA
|
[NCBI]
|
7.99299e-05
|
|
|
JAM3
|
[NCBI]
|
7.9704e-05
|
|
|
EGF
|
[NCBI]
|
7.86576e-05
|
|
|
BSG
|
[NCBI]
|
7.81004e-05
|
|
|
IGHA2
|
[NCBI]
|
7.54653e-05
|
|
|
APC
|
[NCBI]
|
7.351e-05
|
|
|
ARMD3
|
[NCBI]
|
7.19856e-05
|
|
|
ataxic diplegia with defective cellular immunity
|
[NCBI]
|
7.19856e-05
|
|
|
fibrosclerosis, multifocal
|
[NCBI]
|
7.19856e-05
|
|
|
PIGR
|
[NCBI]
|
6.98284e-05
|
|
|
TCRB
|
[NCBI]
|
6.75177e-05
|
|
|
IGSF4C
|
[NCBI]
|
6.51241e-05
|
|
|
dora reverse strand
|
[NCBI]
|
6.51241e-05
|
|
|
IGSF11
|
[NCBI]
|
6.51241e-05
|
|
|
PUNC
|
[NCBI]
|
6.51241e-05
|
|
|
ISLR
|
[NCBI]
|
6.51241e-05
|
|
|
CD244
|
[NCBI]
|
6.50733e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
6.29517e-05
|
|
|
BTK
|
[NCBI]
|
6.26531e-05
|
|
|
BL
|
[NCBI]
|
6.04306e-05
|
|
|
hypoproteinemia, hypercatabolic
|
[NCBI]
|
6.03075e-05
|
|
|
CIDX
|
[NCBI]
|
6.03075e-05
|
|
|
secretory component deficiency
|
[NCBI]
|
6.03075e-05
|
|
|
immunodeficiency, partial combined, with absence of hla determinants and beta-2-microglobulin from lymphocytes
|
[NCBI]
|
6.03075e-05
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
6.03075e-05
|
|
|
TCRG
|
[NCBI]
|
6.00149e-05
|
|
|
IL2
|
[NCBI]
|
5.89263e-05
|
|
|
SIGLEC9
|
[NCBI]
|
5.49109e-05
|
|
|
IGSF6
|
[NCBI]
|
5.49109e-05
|
|
|
KIRREL2
|
[NCBI]
|
5.49109e-05
|
|
|
IGAD2
|
[NCBI]
|
5.28099e-05
|
|
|
bare lymphocyte syndrome, type i
|
[NCBI]
|
5.28099e-05
|
|
|
membranoproliferative glomerulonephritis, x-linked
|
[NCBI]
|
5.28099e-05
|
|
|
IGHV
|
[NCBI]
|
5.18e-05
|
|
|
SN
|
[NCBI]
|
5.10073e-05
|
|
|
OCP
|
[NCBI]
|
5.08287e-05
|
|
|
CD48
|
[NCBI]
|
5.03016e-05
|
|
|
IGHA1
|
[NCBI]
|
5.03016e-05
|
|
|
VSIG4
|
[NCBI]
|
4.71412e-05
|
|
|
SLAMF6
|
[NCBI]
|
4.71412e-05
|
|
|
CNTN4
|
[NCBI]
|
4.71412e-05
|
|
|
IKZF3
|
[NCBI]
|
4.71412e-05
|
|
|
IDDM
|
[NCBI]
|
4.68441e-05
|
|
|
INPP5D
|
[NCBI]
|
4.63673e-05
|
|
|
IGSF1
|
[NCBI]
|
4.47221e-05
|
|
|
BGS
|
[NCBI]
|
4.2955e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
4.2955e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
4.2955e-05
|
|
|
hypogammaglobulinemia and isolated growth hormone deficiency, x-linked
|
[NCBI]
|
4.2955e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
4.2955e-05
|
|
|
chromosome 18q deletion syndrome
|
[NCBI]
|
4.2955e-05
|
|
|
KCS
|
[NCBI]
|
4.2955e-05
|
|
|
ROBO1
|
[NCBI]
|
4.27594e-05
|
|
|
KIR2DL4
|
[NCBI]
|
4.27594e-05
|
|
|
ADA
|
[NCBI]
|
4.0928e-05
|
|
|
POU2AF1
|
[NCBI]
|
3.96809e-05
|
|
|
BCR
|
[NCBI]
|
3.96782e-05
|
|
|
cutis laxa, autosomal dominant
|
[NCBI]
|
3.93849e-05
|
|
|
kindler syndrome
|
[NCBI]
|
3.93849e-05
|
|
|
hyperthyroidism, nonautoimmune
|
[NCBI]
|
3.93849e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
3.84258e-05
|
|
|
HIGM1
|
[NCBI]
|
3.79827e-05
|
|
|
IGHM
|
[NCBI]
|
3.73054e-05
|
|
|
ITGA4
|
[NCBI]
|
3.73054e-05
|
|
|
PECAM1
|
[NCBI]
|
3.73054e-05
|
|
|
ACHE
|
[NCBI]
|
3.71417e-05
|
|
|
PVR
|
[NCBI]
|
3.54227e-05
|
|
|
CFB
|
[NCBI]
|
3.46135e-05
|
|
|
AVP
|
[NCBI]
|
3.43262e-05
|
|
|
complement component 5 deficiency
|
[NCBI]
|
3.37538e-05
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
3.37538e-05
|
|
|
KLK3
|
[NCBI]
|
3.36564e-05
|
|
|
A2M
|
[NCBI]
|
3.35996e-05
|
|
|
TH
|
[NCBI]
|
3.25651e-05
|
|
|
C6ORF21
|
[NCBI]
|
3.25577e-05
|
|
|
HHLA2
|
[NCBI]
|
3.25577e-05
|
|
|
SLAMF9
|
[NCBI]
|
3.25577e-05
|
|
|
IGSF9
|
[NCBI]
|
3.25577e-05
|
|
|
ZBTB22
|
[NCBI]
|
3.25577e-05
|
|
|
PFDN6
|
[NCBI]
|
3.25577e-05
|
|
|
TAPBPL
|
[NCBI]
|
3.25577e-05
|
|
|
MDGA2
|
[NCBI]
|
3.25577e-05
|
|
|
IZUMO1
|
[NCBI]
|
3.25577e-05
|
|
|
IGSF3
|
[NCBI]
|
3.25577e-05
|
|
|
S8
|
[NCBI]
|
3.25577e-05
|
|
|
IGKDEL
|
[NCBI]
|
3.25577e-05
|
|
|
HHLA3
|
[NCBI]
|
3.25577e-05
|
|
|
junctional adhesion molecule 4
|
[NCBI]
|
3.25577e-05
|
|
|
VSIG2
|
[NCBI]
|
3.25577e-05
|
|
|
immunoglobulin superfamily receptor translocation-associated gene 1
|
[NCBI]
|
3.25577e-05
|
|
|
PFC
|
[NCBI]
|
3.16964e-05
|
|
|
FGFR2
|
[NCBI]
|
3.11787e-05
|
|
|
THY1
|
[NCBI]
|
3.10958e-05
|
|
|
FA
|
[NCBI]
|
3.1001e-05
|
|
|
TNFRSF13B
|
[NCBI]
|
3.05284e-05
|
|
|
CCK
|
[NCBI]
|
2.95227e-05
|
|
|
PCNA
|
[NCBI]
|
2.94787e-05
|
|
|
THC1
|
[NCBI]
|
2.94255e-05
|
|
|
apert syndrome
|
[NCBI]
|
2.94255e-05
|
|
|
VEGF
|
[NCBI]
|
2.87532e-05
|
|
|
autoimmune disease
|
[NCBI]
|
2.75967e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
2.75967e-05
|
|
|
IL2RG
|
[NCBI]
|
2.72526e-05
|
|
|
EPO
|
[NCBI]
|
2.71773e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
2.71207e-05
|
|
|
GFAP
|
[NCBI]
|
2.71119e-05
|
|
|
TTN
|
[NCBI]
|
2.6483e-05
|
|
|
CHH
|
[NCBI]
|
2.64453e-05
|
|
|
NPHS1
|
[NCBI]
|
2.59413e-05
|
|
|
TNF
|
[NCBI]
|
2.5346e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.52802e-05
|
|
|
PTH
|
[NCBI]
|
2.52503e-05
|
|
|
immunoglobulin superfamily receptor translocation-associated gene 2
|
[NCBI]
|
2.51465e-05
|
|
|
fc receptor homolog expressed in b cells
|
[NCBI]
|
2.51465e-05
|
|
|
SIGLEC6
|
[NCBI]
|
2.51465e-05
|
|
|
SLAMF7
|
[NCBI]
|
2.51465e-05
|
|
|
TIMD4
|
[NCBI]
|
2.51465e-05
|
|
|
SDK2
|
[NCBI]
|
2.51465e-05
|
|
|
GPA33
|
[NCBI]
|
2.51465e-05
|
|
|
PILRA
|
[NCBI]
|
2.51465e-05
|
|
|
NCR2
|
[NCBI]
|
2.51465e-05
|
|
|
APOBEC3C
|
[NCBI]
|
2.51465e-05
|
|
|
SDK1
|
[NCBI]
|
2.51465e-05
|
|
|
IGHG2
|
[NCBI]
|
2.51465e-05
|
|
|
WDR46
|
[NCBI]
|
2.51465e-05
|
|
|
IGSF8
|
[NCBI]
|
2.51465e-05
|
|
|
CD300LF
|
[NCBI]
|
2.51465e-05
|
|
|
CJD
|
[NCBI]
|
2.46075e-05
|
|
|
TNFRSF14
|
[NCBI]
|
2.44763e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
2.44324e-05
|
|
|
RNASE3
|
[NCBI]
|
2.42167e-05
|
|
|
IKBKG
|
[NCBI]
|
2.4178e-05
|
|
|
PRL
|
[NCBI]
|
2.41767e-05
|
|
|
CFH
|
[NCBI]
|
2.31691e-05
|
|
|
PMC
|
[NCBI]
|
2.30491e-05
|
|
|
LIFR
|
[NCBI]
|
2.25565e-05
|
|
|
NKX2C
|
[NCBI]
|
2.23568e-05
|
|
|
BOC
|
[NCBI]
|
2.23568e-05
|
|
|
RGL2
|
[NCBI]
|
2.23568e-05
|
|
|
PTPRM
|
[NCBI]
|
2.23568e-05
|
|
|
GP6
|
[NCBI]
|
2.23568e-05
|
|
|
CD300A
|
[NCBI]
|
2.23568e-05
|
|
|
TREM1
|
[NCBI]
|
2.23568e-05
|
|
|
neurofascin
|
[NCBI]
|
2.23568e-05
|
|
|
IGHG4
|
[NCBI]
|
2.23568e-05
|
|
|
SIGLEC10
|
[NCBI]
|
2.23568e-05
|
|
|
CD160
|
[NCBI]
|
2.23568e-05
|
|
|
ITGB8
|
[NCBI]
|
2.23568e-05
|
|
|
IGHJ
|
[NCBI]
|
2.23568e-05
|
|
|
IHG
|
[NCBI]
|
2.23568e-05
|
|
|
ews/fli1-activated transcript 2
|
[NCBI]
|
2.23568e-05
|
|
|
CTLA4
|
[NCBI]
|
2.20708e-05
|
|
|
dent disease 1
|
[NCBI]
|
2.17745e-05
|
|
|
CNC1
|
[NCBI]
|
2.17745e-05
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
2.16447e-05
|
|
|
L1CAM
|
[NCBI]
|
2.1167e-05
|
|
|
ALB
|
[NCBI]
|
2.09516e-05
|
|
|
NCR1
|
[NCBI]
|
2.05494e-05
|
|
|
b7 homolog 3
|
[NCBI]
|
2.05494e-05
|
|
|
IGHG3
|
[NCBI]
|
2.05494e-05
|
|
|
SIGIRR
|
[NCBI]
|
2.05494e-05
|
|
|
CD200R1
|
[NCBI]
|
2.05494e-05
|
|
|
OBSCN
|
[NCBI]
|
2.05494e-05
|
|
|
IGLV
|
[NCBI]
|
2.05494e-05
|
|
|
SIGLEC5
|
[NCBI]
|
2.05494e-05
|
|
|
KIR2DL5
|
[NCBI]
|
2.05494e-05
|
|
|
NUCB1
|
[NCBI]
|
2.05494e-05
|
|
|
LY9
|
[NCBI]
|
2.05494e-05
|
|
|
DSCAML1
|
[NCBI]
|
2.05494e-05
|
|
|
CD
|
[NCBI]
|
2.04989e-05
|
|
|
EGFR
|
[NCBI]
|
2.02921e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
1.94997e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
1.94997e-05
|
|
|
POLI
|
[NCBI]
|
1.92086e-05
|
|
|
TSPAN32
|
[NCBI]
|
1.92086e-05
|
|
|
VTCN1
|
[NCBI]
|
1.92086e-05
|
|
|
POU2F2
|
[NCBI]
|
1.92086e-05
|
|
|
CD84
|
[NCBI]
|
1.92086e-05
|
|
|
NEO1
|
[NCBI]
|
1.92086e-05
|
|
|
ROBO3
|
[NCBI]
|
1.92086e-05
|
|
|
PIK3CD
|
[NCBI]
|
1.92086e-05
|
|
|
CRH
|
[NCBI]
|
1.8971e-05
|
|
|
RP1
|
[NCBI]
|
1.84788e-05
|
|
|
PVRL2
|
[NCBI]
|
1.81426e-05
|
|
|
SCN2B
|
[NCBI]
|
1.81426e-05
|
|
|
IL13RA2
|
[NCBI]
|
1.81426e-05
|
|
|
EKV
|
[NCBI]
|
1.75247e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
1.75247e-05
|
|
|
MCP
|
[NCBI]
|
1.74772e-05
|
|
|
MBL2
|
[NCBI]
|
1.72808e-05
|
|
|
PRKCB1
|
[NCBI]
|
1.72582e-05
|
|
|
CD1B
|
[NCBI]
|
1.72582e-05
|
|
|
PNOC
|
[NCBI]
|
1.72582e-05
|
|
|
CD22
|
[NCBI]
|
1.72582e-05
|
|
|
ROBO2
|
[NCBI]
|
1.72582e-05
|
|
|
TTID
|
[NCBI]
|
1.72582e-05
|
|
|
TICAM1
|
[NCBI]
|
1.72582e-05
|
|
|
AXL
|
[NCBI]
|
1.72582e-05
|
|
|
ANK3
|
[NCBI]
|
1.72582e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
1.66306e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.66145e-05
|
|
|
MYC
|
[NCBI]
|
1.65041e-05
|
|
|
FBLN5
|
[NCBI]
|
1.65029e-05
|
|
|
LILRB1
|
[NCBI]
|
1.65029e-05
|
|
|
CDON
|
[NCBI]
|
1.65029e-05
|
|
|
IL1RL1
|
[NCBI]
|
1.5844e-05
|
|
|
IL21R
|
[NCBI]
|
1.5844e-05
|
|
|
IGKV
|
[NCBI]
|
1.5844e-05
|
|
|
GNAI2
|
[NCBI]
|
1.5844e-05
|
|
|
DAXX
|
[NCBI]
|
1.5844e-05
|
|
|
ELOVL4
|
[NCBI]
|
1.5844e-05
|
|
|
DSCAM
|
[NCBI]
|
1.52601e-05
|
|
|
CD28
|
[NCBI]
|
1.52601e-05
|
|
|
IRF4
|
[NCBI]
|
1.52601e-05
|
|
|
TRAF1
|
[NCBI]
|
1.52601e-05
|
|
|
ITGA5
|
[NCBI]
|
1.52601e-05
|
|
|
TNFSF13
|
[NCBI]
|
1.52601e-05
|
|
|
ERN1
|
[NCBI]
|
1.52601e-05
|
|
|
HAVCR1
|
[NCBI]
|
1.52601e-05
|
|
|
NCAM1
|
[NCBI]
|
1.47359e-05
|
|
|
OAS1
|
[NCBI]
|
1.47359e-05
|
|
|
HLA-A
|
[NCBI]
|
1.46288e-05
|
|
|
LPL
|
[NCBI]
|
1.43666e-05
|
|
|
IGHE
|
[NCBI]
|
1.42607e-05
|
|
|
SUZ12
|
[NCBI]
|
1.42607e-05
|
|
|
TREM2
|
[NCBI]
|
1.42607e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
1.42552e-05
|
|
|
CMD1A
|
[NCBI]
|
1.42552e-05
|
|
|
BDNF
|
[NCBI]
|
1.40278e-05
|
|
|
NSEP1
|
[NCBI]
|
1.38262e-05
|
|
|
NLRP3
|
[NCBI]
|
1.38262e-05
|
|
|
ID3
|
[NCBI]
|
1.38262e-05
|
|
|
APOBEC1
|
[NCBI]
|
1.38262e-05
|
|
|
XBP1
|
[NCBI]
|
1.38262e-05
|
|
|
FLNB
|
[NCBI]
|
1.34261e-05
|
|
|
FYN
|
[NCBI]
|
1.34261e-05
|
|
|
POLH
|
[NCBI]
|
1.30556e-05
|
|
|
PKHD1
|
[NCBI]
|
1.30556e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.29925e-05
|
|
|
LU
|
[NCBI]
|
1.27106e-05
|
|
|
CD209
|
[NCBI]
|
1.27106e-05
|
|
|
NPHS1
|
[NCBI]
|
1.23879e-05
|
|
|
PIK3R1
|
[NCBI]
|
1.23879e-05
|
|
|
PDCD1
|
[NCBI]
|
1.23879e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
1.22545e-05
|
|
|
APOBEC3G
|
[NCBI]
|
1.2085e-05
|
|
|
IL9
|
[NCBI]
|
1.2085e-05
|
|
|
MME
|
[NCBI]
|
1.17996e-05
|
|
|
FLT4
|
[NCBI]
|
1.17996e-05
|
|
|
PCCA
|
[NCBI]
|
1.15299e-05
|
|
|
PTPN22
|
[NCBI]
|
1.15299e-05
|
|
|
TLR9
|
[NCBI]
|
1.14278e-05
|
|
|
PAX5
|
[NCBI]
|
1.10315e-05
|
|
|
LCK
|
[NCBI]
|
1.10315e-05
|
|
|
CEACAM6
|
[NCBI]
|
1.10315e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
1.10103e-05
|
|
|
ITGB1
|
[NCBI]
|
1.08002e-05
|
|
|
PI
|
[NCBI]
|
1.06056e-05
|
|
|
SELP
|
[NCBI]
|
1.05796e-05
|
|
|
CLL
|
[NCBI]
|
1.05478e-05
|
|
|
MBP
|
[NCBI]
|
9.8214e-06
|
|
|
ALCAM
|
[NCBI]
|
9.7868e-06
|
|
|
MYD88
|
[NCBI]
|
9.7868e-06
|
|
|
HGF
|
[NCBI]
|
9.69142e-06
|
|
|
CML
|
[NCBI]
|
9.5445e-06
|
|
|
FCAS
|
[NCBI]
|
9.5445e-06
|
|
|
AICDA
|
[NCBI]
|
9.43534e-06
|
|
|
F3
|
[NCBI]
|
9.1639e-06
|
|
|
CD2AP
|
[NCBI]
|
8.95345e-06
|
|
|
DNMT3B
|
[NCBI]
|
8.65815e-06
|
|
|
complement component 6 deficiency
|
[NCBI]
|
8.65815e-06
|
|
|
BCL6
|
[NCBI]
|
8.65815e-06
|
|
|
AGER
|
[NCBI]
|
8.6537e-06
|
|
|
DGS
|
[NCBI]
|
8.48062e-06
|
|
|
PSIP1
|
[NCBI]
|
8.38088e-06
|
|
|
RAG1
|
[NCBI]
|
8.38088e-06
|
|
|
NOD2
|
[NCBI]
|
8.24839e-06
|
|
|
CYP2A6
|
[NCBI]
|
8.11972e-06
|
|
|
IL5
|
[NCBI]
|
7.99466e-06
|
|
|
INHBA
|
[NCBI]
|
7.87303e-06
|
|
|
ARPKD
|
[NCBI]
|
7.80352e-06
|
|
|
AFP
|
[NCBI]
|
7.45112e-06
|
|
|
HLA-DRA
|
[NCBI]
|
7.41768e-06
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
7.4163e-06
|
|
|
ALPS
|
[NCBI]
|
7.34726e-06
|
|
|
SLC16A1
|
[NCBI]
|
7.31093e-06
|
|
|
HHC1
|
[NCBI]
|
7.04621e-06
|
|
|
DCC
|
[NCBI]
|
6.90874e-06
|
|
|
NGFB
|
[NCBI]
|
6.60731e-06
|
|
|
CDH1
|
[NCBI]
|
6.1245e-06
|
|
|
BCL2
|
[NCBI]
|
5.969e-06
|
|
|
C3
|
[NCBI]
|
5.969e-06
|
|
|
NP
|
[NCBI]
|
5.60507e-06
|
|
|
MAPK3
|
[NCBI]
|
5.14717e-06
|
|
|
JAK3
|
[NCBI]
|
5.14717e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
5.13914e-06
|
|
|
BLM
|
[NCBI]
|
4.86708e-06
|
|
|
BMP2
|
[NCBI]
|
4.79495e-06
|
|
|
HP
|
[NCBI]
|
4.7011e-06
|
|
|
ALD
|
[NCBI]
|
4.67635e-06
|
|
|
TSHR
|
[NCBI]
|
4.6309e-06
|
|
|
PTK2
|
[NCBI]
|
4.56688e-06
|
|
|
SDC2
|
[NCBI]
|
4.38878e-06
|
|
|
HBG1
|
[NCBI]
|
4.37336e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
4.18493e-06
|
|
|
MPZ
|
[NCBI]
|
4.18033e-06
|
|
|
HRG
|
[NCBI]
|
3.99778e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
3.91015e-06
|
|
|
MPO
|
[NCBI]
|
3.87479e-06
|
|
|
CCL22
|
[NCBI]
|
3.82483e-06
|
|
|
CPE
|
[NCBI]
|
3.50477e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
3.42484e-06
|
|
|
IL4
|
[NCBI]
|
3.39279e-06
|
|
|
LBP
|
[NCBI]
|
3.28485e-06
|
|
|
NRG1
|
[NCBI]
|
3.24972e-06
|
|
|
TNFSF11
|
[NCBI]
|
2.98309e-06
|
|
|
SHBG
|
[NCBI]
|
2.8876e-06
|
|
|
HAE
|
[NCBI]
|
2.88281e-06
|
|
|
HBB
|
[NCBI]
|
2.6727e-06
|
|
|
RNASE2
|
[NCBI]
|
2.62588e-06
|
|
|
OSM
|
[NCBI]
|
2.5565e-06
|
|
|
PG
|
[NCBI]
|
2.51685e-06
|
|
|
CP
|
[NCBI]
|
2.34608e-06
|
|
|
ACPP
|
[NCBI]
|
2.33256e-06
|
|
|
RB1
|
[NCBI]
|
2.31213e-06
|
|
|
SHH
|
[NCBI]
|
2.15625e-06
|
|
|
KDR
|
[NCBI]
|
2.14636e-06
|
|
|
PSORS1
|
[NCBI]
|
2.07649e-06
|
|
|
IBD1
|
[NCBI]
|
1.93619e-06
|
|
|
TPO
|
[NCBI]
|
1.77317e-06
|
|
|
hemophilia a
|
[NCBI]
|
1.76968e-06
|
|
|
CHS
|
[NCBI]
|
1.71364e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
1.67963e-06
|
|
|
DHFR
|
[NCBI]
|
1.62357e-06
|
|
|
KITLG
|
[NCBI]
|
1.62226e-06
|
|
|
IL6
|
[NCBI]
|
1.50214e-06
|
|
|
VIP
|
[NCBI]
|
1.3765e-06
|
|
|
TTR
|
[NCBI]
|
1.35572e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
1.10727e-06
|
|
|
G6PD
|
[NCBI]
|
1.09416e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.02919e-06
|
|
|
PRNP
|
[NCBI]
|
1.01799e-06
|
|
|
FAAH
|
[NCBI]
|
9.13222e-07
|
|
|
PF4
|
[NCBI]
|
7.77755e-07
|
|
|
FGFR3
|
[NCBI]
|
6.03974e-07
|
|
|
MUC1
|
[NCBI]
|
5.58599e-07
|
|
|
TLR2
|
[NCBI]
|
5.47867e-07
|
|
|
TG
|
[NCBI]
|
4.94475e-07
|
|
|
ACP5
|
[NCBI]
|
4.09809e-07
|
|
|
SOD1
|
[NCBI]
|
4.07167e-07
|
|
|
APRT
|
[NCBI]
|
4.07167e-07
|
|
|
SERPINA6
|
[NCBI]
|
3.35449e-07
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
2.94938e-07
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
2.94938e-07
|
|
|
CD
|
[NCBI]
|
1.46534e-07
|
|
|
LRP1
|
[NCBI]
|
1.13387e-07
|
|
|
GPI
|
[NCBI]
|
9.93343e-08
|
|
|
FMF
|
[NCBI]
|
8.41735e-08
|
|
|
TF
|
[NCBI]
|
2.56758e-08
|
|
|
MS
|
[NCBI]
|
5.96713e-09
|
|